Skip to main content
. Author manuscript; available in PMC: 2009 Jun 8.
Published in final edited form as: Lung Cancer. 2007 Apr 8;57(2):143–151. doi: 10.1016/j.lungcan.2007.03.002

Table 4.

Distributions of the number of putative SHMT1 risk variant genotypes in the combined genotypes of lung cancer cases and cancer-free controls and the association with risk of lung cancer

Putative SHMT1 risk variants genotype a Number of subjects (%)
Pb Crude OR (95% CI) Adjusted OR (95% CI)c
Patients Controls
Total 1032 (100.0) 1145 (100.0)
0 1 (0.1) 1 (0.1) 0.269
1 37 (3.6) 62 (5.4)
2 498 (48.3) 573 (50.0)
3 468 (45.4) 484 (42.3)
4 26 (2.5) 24 (2.1)
5 2 (0.2) 1 (0.1)
0–1 38 (3.7) 63 (5.5) 0.056 1.00 1.00
2 498 (48.3) 573 (50.0) 1.44 (0.95–2.19) 1.39 (0.89–2.18)
3+ 496 (48.1) 509 (44.5) 1.62 (1.06–2.46) 1.65 (1.05–2.57)
Ptrend = 0.029 Ptrend = 0.013
0–2 536 (51.9) 636 (55.5) 0.092 1.00 1.00
3+ 496 (48.1) 509 (44.5) 1.16 (0.98–1.37) 1.21 (1.01–1.45)
a

Constructed from the combination of dichotomized genotypes as shown in Table 2.

b

Two-sided χ2 test for the difference in the genotype or allele distributions between the cases and the controls.

c

Due to missing data, 932 cases and 1073 controls were analyzed with adjustment for age, sex, smoking status, square root of pack-years smoked, alcohol drinking status, and dietary intake of total folate, vitamin B6, vitamin B12, and methionine in logistic regression models.